Cargando…
Elevated Erythritol: A Marker of Metabolic Dysregulation or Contributor to the Pathogenesis of Cardiometabolic Disease?
Erythritol is a non-nutritive sugar replacement that can be endogenously produced by humans. Witkowski et al. reported that elevated circulating erythritol is associated with adverse cardiovascular events in three independent cohorts, demonstrated in vitro and ex vivo that erythritol promotes platel...
Autores principales: | Mazi, Tagreed A., Stanhope, Kimber L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534702/ https://www.ncbi.nlm.nih.gov/pubmed/37764794 http://dx.doi.org/10.3390/nu15184011 |
Ejemplares similares
-
Erythritol: An In-Depth Discussion of Its Potential to Be a Beneficial Dietary Component
por: Mazi, Tagreed A., et al.
Publicado: (2023) -
The sugar-free paradox: cardiometabolic consequences of erythritol
por: Pafili, Kalliopi, et al.
Publicado: (2023) -
Lipid and energy metabolism in Wilson disease()
por: Mazi, Tagreed A., et al.
Publicado: (2020) -
TV and Inactivity Are Separate Contributors to Metabolic Risk Factors in Children
por: Prentice, Andrew, et al.
Publicado: (2006) -
Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes
por: Mazi, Tagreed A., et al.
Publicado: (2019)